This document discusses challenges in diagnosing and treating young onset dementia. It defines young onset dementia as occurring before age 65. Two case studies are presented, one with a 53-year-old woman experiencing language difficulties, and another with a 34-year-old woman initially diagnosed with depression but later found to have Alzheimer's disease. Diagnostic challenges include differentiating dementia from other conditions, identifying non-amnestic variants that present atypically, and determining genetic causes. Early onset dementia is often misdiagnosed due to its varied presentations.
Classification of Speech Disorders - A Brief OverviewShazia Tahira
Classification of Speech Disorders - A Brief Overview
Summarizing the Main Points about the Classification of Speech Disorders including Speech Sound Disorders, Fluency Disorders and Voice Disorders
Classification of Speech Disorders - A Brief OverviewShazia Tahira
Classification of Speech Disorders - A Brief Overview
Summarizing the Main Points about the Classification of Speech Disorders including Speech Sound Disorders, Fluency Disorders and Voice Disorders
Every child that appears to have speech delay is not really the way it seems in each case. unless there is a clear hearing/ larynx deficit , there cangt be true speech delay. Its very prudent to pick up associated feature of communication delay, social delay, sensory issues and audiotory processing defects early without wasting time. A visit to a neuro developmental pediatrician usually helps solve the confusion in diagnosis. A delayed diagnosis may make them permanent disability. Dr kondekar addresses various forms of social communication and speech patterns that may point towards autism evaluation. Read Dr Kondekars way to manage autism DSM 5 way at www.pedneuro.in
This presentation is about Language Disorders, their symptoms and treatment. It also tells how parents can help their own children who suffer from such disorders.
Every child that appears to have speech delay is not really the way it seems in each case. unless there is a clear hearing/ larynx deficit , there cangt be true speech delay. Its very prudent to pick up associated feature of communication delay, social delay, sensory issues and audiotory processing defects early without wasting time. A visit to a neuro developmental pediatrician usually helps solve the confusion in diagnosis. A delayed diagnosis may make them permanent disability. Dr kondekar addresses various forms of social communication and speech patterns that may point towards autism evaluation. Read Dr Kondekars way to manage autism DSM 5 way at www.pedneuro.in
This presentation is about Language Disorders, their symptoms and treatment. It also tells how parents can help their own children who suffer from such disorders.
any of various difficulties (such as a physical, emotional, behavioral, or learning disability or impairment) that causes an individual to require additional or specialized services or accommodations (such as in education or recreation) students with special needs.
parts of brain which are involved in the production and comprehension of the speech,speech errors i-e tongue tips and slips,aphasias and the role of clinical linguistic have been discussed in this presentation
You can email me martzmonette@yahoo.com for inquiry. You can send me a request stating your purpose for the need to have a copy of this presentation. Thank you very much!
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
4. DEFINITIONS
YOD
Young-onset dementia
(YOD) refers to patients
diagnosed with dementia
before 65 years of age.
YOD is a relatively
common, but frequently
misdiagnosed, condition.
PRESENILE?
EARLY ONSET?
5. DEFINITIONS
YOD
Young-onset dementia
(YOD) refers to patients
diagnosed with dementia
before 65 years of age.
YOD is a relatively
common, but frequently
misdiagnosed, condition.
PRESENILE?
Before 45Y
EARLY ONSET?
6. DEFINITIONS
YOD
Young-onset dementia
(YOD) refers to patients
diagnosed with dementia
before 65 years of age.
YOD is a relatively
common, but frequently
misdiagnosed, condition.
PRESENILE?
Before 45Y
EARLY ONSET?
● Early-onset Alzheimer disease, which makes
up about 5% to 6% of all cases of Alzheimer
disease, is distinct from late-onset
Alzheimer disease in a number of clinical,
genetic, neurobiological, and management
features.
7. CASE
53y
F
2-year history of a
progressive decline in her
ability to find words and
pronounce them correctly.
She also could not repeat
or understand sentences
when they were too long.
Investigatio
ns
neuropsychological testing that
showed normal intellectual abilities
except for a decline in verbal
fluency, with more minor changes in
auditory attention and visual
memory.
unremarkable MRI of the
brain, normal routine
laboratory results,
8. 1st challenge ?
Is it
dementia?
Dementia is a syndrome
in which there is
deterioration in
memory, thinking,
behavior and the ability
to perform everyday
9. 1st challenge ?
Is it
dementia?
Dementia is a syndrome
in which there is
deterioration in
memory, thinking,
behavior and the ability
to perform everyday
ACTU
AL
G.K. Gouras, in Reference Module in
Biomedical Sciences, 2014
Dementia is a chronic
decline in cognitive
function that causes
impairment relative to a
person's previous level of
social and occupational
functioning.
17. Episodic Memory
◆ Forgetting recent eventsa
◆ Misplacing personal itemsa
◆ Asking repetitive questionsa
◆ Missing appointmentsa
◆ Paying bills latea
◆ Poor long term/ autobiographical
memory
Visuospatial
◆ Navigational problems/getting
losta
◆ Difficulty locating items in plain
sight
◆ Problems visually recognizing
faces or objects
Language
◆ Difficulty retrieving words or
namesa
◆ Problems comprehending words or
sentences
◆ Effortful or nonfluent speech
◆ Grammar errors or omissions
◆ Spelling errors
◆ Problems reading and writing
18. Episodic Memory
◆ Forgetting recent eventsa
◆ Misplacing personal itemsa
◆ Asking repetitive questionsa
◆ Missing appointmentsa
◆ Paying bills latea
◆ Poor long term/ autobiographical
memory
Visuospatial
◆ Navigational problems/getting
losta
◆ Difficulty locating items in plain
sight
◆ Problems visually recognizing
faces or objects
Language
◆ Difficulty retrieving words or
namesa
◆ Problems comprehending words or
sentences
◆ Effortful or nonfluent speech
◆ Grammar errors or omissions
◆ Spelling errors
◆ Problems reading and writing
Executive Functions
◆ Problems organizing, multitasking,
or maintaining focusa
◆ Distractibilitya
◆ Difficulty reasoning, problem
solving, or making decisionsa
◆ Poor judgment
19. Other Cognitive
◆ Problems with calculationsa
◆ Difficulty using
devices/technologya
◆ Disorientation to time and plac
20. Other Cognitive
◆ Problems with calculationsa
◆ Difficulty using
devices/technologya
◆ Disorientation to time and plac
Sleep
◆ Insomniaa
◆ Loud snoring/gasping for air
◆ Dream enactment behavior
21. Other Cognitive
◆ Problems with calculationsa
◆ Difficulty using
devices/technologya
◆ Disorientation to time and plac
Sleep
◆ Insomniaa
◆ Loud snoring/gasping for air
◆ Dream enactment behavior
General and Autonomic
◆ Weight lossa or gain
◆ Changes in eating behavior and
dietary preferences
◆ Positional dizziness
◆ Bladder or bowel incontinence
◆ Sexual dysfunction
22. Other Cognitive
◆ Problems with calculationsa
◆ Difficulty using
devices/technologya
◆ Disorientation to time and plac
Psychiatric/Behavioral
◆ Depressiona
◆ Apathya
◆ Anxietya
◆ Irritabilitya
◆ Agitation
◆ Poor impulse control, lability
◆ Delusions
◆ Hallucinations or misperceptions
◆ Changes in personality
◆ New hobbies or interests
◆ Obsessive or compulsive
behaviors
◆ Loss of empathy
◆ Disinhibition
◆ Poor hygiene
Sleep
◆ Insomniaa
◆ Loud snoring/gasping for air
◆ Dream enactment behavior
General and Autonomic
◆ Weight lossa or gain
◆ Changes in eating behavior and
dietary preferences
◆ Positional dizziness
◆ Bladder or bowel incontinence
◆ Sexual dysfunction
23. CASE
53y
F
2-year history of a
progressive decline in her
ability to find words and
pronounce them correctly.
She also could not repeat
or understand sentences
when they were too long.
Investigatio
ns
neuropsychological testing that
showed normal intellectual abilities
except for a decline in verbal
fluency, with more minor changes in
auditory attention and visual
memory.
unremarkable MRI of the
brain, normal routine
laboratory results,
24. CASE CONT.
EXAM
List key cost goals, expenditure
limits
On examination, she had a
Mini-Mental State
Examination(MMSE) score
of 17/30. She could not do
the serial reversals and
could not come up with the
word watch.
Memory examination was
intact on delayed recall;
however, her language
examination was quite
abnormal. She showed
word-finding pauses,
hesitations, and frequent
phonemic paraphasic errors
she had prominent
difficulty with
repetition, quickly breaking
down if a sentence was
more than a few words
26. Case 2#
34-year-old Jordanian woman who was
referred to mainstream mental health
services because of irritability, agitation, loss
of appetite, withdrawal from family activities
and sleeping difficulties. she was initially
diagnosed with major depressive disorder
but subsequently showed very poor
response to antidepressant therapy. Her
presentation gradually and dramatically
progressed into full blown dementia within
couple of years. Brain MrI showed atrophic
cortical changes and subcortical white
matter alterations consistent with
alzheimer’s dementia. Brain pet scan
revealed reduction in cerebral glucose
metabolism in temporoparietal areas
bilaterally most consistent with alzheimer’s
dementia. there was a strong family history
36. ● Logopenic variant primary
progressive aphasia, the most
common nonamnestic
phenotypic variant of early-
onset AD, presents with a
progressive decline in
language with relatively
spared memory and cognition
due to focal AD
neuropathology in
temporoparietal language
areas in the left
hemisphere, especially the
superior/ midtemporal gyrus,
angular gyrus, and midfrontal
cortex.
37. ● Logopenic variant primary
progressive aphasia, the most
common nonamnestic
phenotypic variant of early-
onset AD, presents with a
progressive decline in
language with relatively
spared memory and cognition
due to focal AD
neuropathology in
temporoparietal language
areas in the left
hemisphere, especially the
superior/ midtemporal gyrus,
angular gyrus, and midfrontal
cortex.
● Posterior cortical atrophy,
the second most common
early-onset Alzheimer
disease variant, presents
with progressive and
disproportionate loss
of visuospatial or
visuoperceptual functions,
usually due to Alzheimer
neurodegeneration of
posterior visual cortical
regions.
38. ● Logopenic variant primary
progressive aphasia, the most
common nonamnestic
phenotypic variant of early-
onset AD, presents with a
progressive decline in
language with relatively
spared memory and cognition
due to focal AD
neuropathology in
temporoparietal language
areas in the left
hemisphere, especially the
superior/ midtemporal gyrus,
angular gyrus, and midfrontal
cortex.
● Posterior cortical atrophy,
the second most common
early-onset Alzheimer
disease variant, presents
with progressive and
disproportionate loss
of visuospatial or
visuoperceptual functions,
usually due to Alzheimer
neurodegeneration of
posterior visual cortical
regions.
● The frontal variant of
Alzheimer disease, now
known as behavioral/
dysexecutive Alzheimer
disease, presents with
features suggestive of
frontotemporal lobar
degeneration but most
commonly with apathy or
abulia.
43. ◆ Large percentage of nonamnestic phenotypic variants
(logopenic variant primary progressive aphasia, posterior
cortical atrophy, behavioral/dysexecutive, acalculia,
corticobasal syndrome)
44. ◆ Large percentage of nonamnestic phenotypic variants
(logopenic variant primary progressive aphasia, posterior
cortical atrophy, behavioral/dysexecutive, acalculia,
corticobasal syndrome)
◆ Genetic predisposition: About 1 in 10 patients has an
autosomal dominant familial Alzheimer disease (PSEN1,
PSEN2, APP), and there is a high polygenic risk score of
susceptibility genes
45. ◆ Large percentage of nonamnestic phenotypic variants
(logopenic variant primary progressive aphasia, posterior
cortical atrophy, behavioral/dysexecutive, acalculia,
corticobasal syndrome)
◆ Genetic predisposition: About 1 in 10 patients has an
autosomal dominant familial Alzheimer disease (PSEN1,
PSEN2, APP), and there is a high polygenic risk score of
susceptibility genes
◆ More aggressive course with high rate of mortality
46. ◆ Large percentage of nonamnestic phenotypic variants
(logopenic variant primary progressive aphasia, posterior
cortical atrophy, behavioral/dysexecutive, acalculia,
corticobasal syndrome)
◆ Genetic predisposition: About 1 in 10 patients has an
autosomal dominant familial Alzheimer disease (PSEN1,
PSEN2, APP), and there is a high polygenic risk score of
susceptibility genes
◆ More aggressive course with high rate of mortality
◆ Delay in diagnosis of about 1.6 years
47. ◆ Higher prevalence of traumatic brain injury (which lowers
age of onset) and lower vascular risk factors
48. ◆ Higher prevalence of traumatic brain injury (which lowers
age of onset) and lower vascular risk factors
◆ Overall less semantic memory impairment and greater
attention, executive, praxis, and visuospatial difficulties
49. ◆ Higher prevalence of traumatic brain injury (which lowers
age of onset) and lower vascular risk factors
◆ Overall less semantic memory impairment and greater
attention, executive, praxis, and visuospatial difficulties
◆ Greater psychosocial problems (unexpected midlife “out-of-
step” loss; continued work, financial, family responsibilities;
retained insight with depression, anxiety, suicide risk)
50. ◆ Higher prevalence of traumatic brain injury (which lowers
age of onset) and lower vascular risk factors
◆ Overall less semantic memory impairment and greater
attention, executive, praxis, and visuospatial difficulties
◆ Greater psychosocial problems (unexpected midlife “out-of-
step” loss; continued work, financial, family responsibilities;
retained insight with depression, anxiety, suicide risk)
◆ Hippocampal sparing and less mesial temporal lobe
disease
◆ Greater posterior (parietal, temporoparietal junction)
neocortical atrophy and hypometabolism versus temporal
atrophy and hypometabolism
51. ◆ Higher burden of tau/neurofibrillary tangles per gray matter
atrophy and stage of dementia, especially in focal phenotypic
areas (reflected in tau imaging)
52. ◆ Higher burden of tau/neurofibrillary tangles per gray matter
atrophy and stage of dementia, especially in focal phenotypic
areas (reflected in tau imaging)
◆ Greater involvement of white matter tracts in posterior
association areas and frontoparietal networks and greater
involvement of non–default mode neural networks rather than
the default mode network
59. How to treat?
How did that work? Right set of
people?
Strategies for pharmacologic
management of YOD are similar
to those for late-onset
dementia; currently, no YOD-
specific pharmacologic therapies
are available.
In general, pharmacologic
management strategies include
the use of cholinesterase
inhibitors (ChEIs) and the N-
methyl-D-aspartate (NMDA)
antagonist, memantine (ie,
antidementia drugs), and other
62. How to treat?
How did that work? Right set of
people?
Strategies for pharmacologic
management of YOD are similar
to those for late-onset
dementia; currently, no YOD-
specific pharmacologic therapies
are available.
In general, pharmacologic
management strategies include
the use of cholinesterase
inhibitors (ChEIs) and the N-
methyl-D-aspartate (NMDA)
antagonist, memantine (ie,
antidementia drugs), and other
Donanemab
Aducanumab
75. • YOD is a challenge in
diagnosis (don’t wait
for memory defect)
76. • YOD is a challenge in
diagnosis (don’t wait
for memory defect)
• YOD is a challenge in
DD (Don’t forget
PNLE,NPNLE,Vascular)
77. • YOD is a challenge in
diagnosis (don’t wait
for memory defect)
• YOD is a challenge in
DD (Don’t forget
PNLE,NPNLE,Vascular)
• YOD is a challenge in
ttt (don’t stick hardly
to rules, new hope in
the horizon)